NYLIM Candriam International Equity ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
NYLIM Candriam International Equity ETF IQSI
Morningstar’s Analysis IQSI
Will IQSI outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
ASML Holding NV | 5.06 | 13M | Technology |
Roche Holding AG Ordinary Shares new | 2.08 | 5M | Healthcare |
Nestle SA | 1.70 | 4M | Consumer Defensive |
AstraZeneca PLC | 1.69 | 4M | Healthcare |
Novartis AG Registered Shares | 1.59 | 4M | Healthcare |
Siemens AG | 1.57 | 4M | Industrials |
SAP SE | 1.51 | 4M | Technology |
Schneider Electric SE | 1.33 | 3M | Industrials |
Tokyo Electron Ltd | 1.31 | 3M | Technology |
Advantest Corp | 1.28 | 3M | Technology |